Neurosciences
ROCHESTER, Minn. — An international study led by Mayo Clinic researchers has identified interleukin-6 (IL-6) receptor blockers as a promising option for preventing relapses in[...]
Latest stories
Individualized Medicine
July 30, 2025
Featured News
July 28, 2025
Research
July 11, 2025
Medical Innovation
July 7, 2025
International
June 30, 2025
Sign up to receive email notifications
Explore more topics
Sign up
Mayo Clinic Connect
An online patient support community